The pharmaceutical industry\u2019s research and development marathon \u2014 stretching 10 to 12 years from hypothesis to approval \u2014 is set to shrink as AI-driven drug development compresses that timeline.<\/p>\n
The shift from AI experimentation to real transformation of business workflows<\/a> is accelerating across industries, but few examples carry higher stakes than pharma, where a drug\u2019s failure at phase three of a clinical trial means patients have been waiting nearly a decade for nothing. Governing data at enterprise scale is the prerequisite, according to Emmanuel Frenehard<\/a> (pictured, left), chief digital officer of Sanofi S.A.<\/p>\n \u201cWe believe, I believe, that we\u2019ll be able to see and we\u2019re starting to simulate even clinical trials before they happen,\u201d Frenehard said. \u201cSo we still have to do them, but we do them with more precision. We do them with a better appreciation of the kind of patients we need in those trials. My intention is to have the time it takes \u2014 so from 10 to 12 to five to six.\u201d<\/p>\n Frenehard and Dayne Turbitt<\/a> (pictured, right), senior vice president of EMEA at Snowflake Inc., spoke with theCUBE\u2019s Dave Vellante<\/a> and Rebecca Knight<\/a> at Snowflake Summit 2026<\/a>, during an exclusive broadcast on theCUBE, SiliconANGLE Media\u2019s livestreaming studio. They discussed AI-driven drug development, agentic workflows and how a unified data foundation enables AI to reinvent enterprise processes.<\/p>\n (* Disclosure below.)<\/p>\n AI-driven drug development and the case for unified data<\/p>\n Frenehard laid out a striking vision for how AI can attack the pharmaceutical development cycle at every stage. A core strategic principle at the company is that 90% of drugs still fail at phase three of a clinical trial, Frenehard noted.\u2014 close to the finish line, with patients already waiting.<\/p>\n \u201cWe believe, I believe, that we\u2019ll be able to see and we\u2019re starting to simulate even clinical trials before they happen,\u201d Frenehard said. \u201cSo we still have to do them, but we do them with more precision. We do them with a better appreciation of the kind of patients we need in those trials. My intention is to have the time it takes \u2014 so from 10 to 12 to five to six.\u201d<\/p>\n Achieving that ambition requires a single, governed data environment as its foundation. Fragmented data is the enemy of AI precision, both speakers agreed. Sanofi\u2019s answer is to run all workflows directly on a unified platform<\/a> \u2014 treating Snowflake as an operating system rather than a database \u2014 removing the need for intermediary systems and ensuring intelligence is never siloed, Frenehard explained.<\/p>\n \u201cAll our data shall be on Snowflake and shall be what we call AI ready data, which means it\u2019s governed, which means of quality we can trust,\u201d Frenehard said. \u201cThe workflow is what runs on top of the data. And so with Snowflake and the ability that \u2026 Snowflake is an operating system, it\u2019s not just a data platform.\u201d<\/p>\n Here\u2019s the complete video interview, part of SiliconANGLE\u2019s and theCUBE\u2019s coverage of\u00a0Snowflake Summit 2026<\/a> event:<\/p>\n (* Disclosure: heCUBE is a paid media partner for Snowflake Summit 2026. Sponsors of theCUBE\u2019s event coverage do not have editorial control over content on theCUBE or SiliconANGLE.)<\/p>\n Photo: SiliconANGLE<\/p>\n Support our mission to keep content open and free by engaging with theCUBE community. Join theCUBE\u2019s Alumni Trust Network, where technology leaders connect, share intelligence and create opportunities.<\/p>\n 15M+ viewers of theCUBE videos, powering conversations across AI, cloud, cybersecurity and more About SiliconANGLE Media<\/p>\n SiliconANGLE Media is a recognized leader in digital media innovation, uniting breakthrough technology, strategic insights and real-time audience engagement. As the parent company of SiliconANGLE<\/a>, theCUBE Network<\/a>, theCUBE Research<\/a>, CUBE365<\/a>, theCUBE AI<\/a> and theCUBE SuperStudios \u2014 with flagship locations in Silicon Valley and the New York Stock Exchange \u2014 SiliconANGLE Media operates at the intersection of media, technology and AI.<\/p>\n Founded by tech visionaries John Furrier and Dave Vellante, SiliconANGLE Media has built a dynamic ecosystem of industry-leading digital media brands that reach 15+ million elite tech professionals. Our new proprietary theCUBE AI Video Cloud is breaking ground in audience interaction, leveraging theCUBEai.com neural network to help technology companies make data-driven decisions and stay at the forefront of industry conversations.<\/p>\n","protected":false},"excerpt":{"rendered":"The pharmaceutical industry\u2019s research and development marathon \u2014 stretching 10 to 12 years from hypothesis to approval \u2014…\n","protected":false},"author":2,"featured_media":30128,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12983],"tags":[21839,13012,21840,12929],"class_list":["post-30127","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sanofi","tag-ryan-stevens","tag-sanofi","tag-sanofi-aims-to-cut-ai-driven-drug-development-timelines-in-half-with-snowflake","tag-siliconangle"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts\/30127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/comments?post=30127"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts\/30127\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/media\/30128"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/media?parent=30127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/categories?post=30127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/tags?post=30127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n11.4k+ theCUBE alumni \u2014 Connect with more than 11,400 tech and business leaders shaping the future through a unique trusted-based network.<\/p>\n